Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant DCF vs CF in Locally Advanced Inoperable SCCHN
NCT00995293Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2009
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Sanofi. Started Aug 2009; status: completed.
02
Drugs
docetaxel
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00995293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00995293.